The novel CAR T-cell therapy – Yescarta from Fosun Kite has recently been approved by the National Medical Products Administration (NMPA) in China.
The novel CAR T-cell therapy – Yescarta from Fosun Kite has recently been approved by the National Medical Products Administration (NMPA) in China.